AAPC CPC Exam With Confidence Using Practice Dumps

Procedure Coding:

56633 – Radical vulvectomy (removal of > 80%), including deep subcutaneous tissue

Documentation supports greater than 80% vulvar removal

Deep tissue involvement confirms radical procedure

Diagnosis Coding:

D07.1 – Carcinoma in situ of vulva

VIN III = high-grade squamous intraepithelial lesion

Classified as carcinoma in situ, not benign dysplasia

Why Other Options Are Incorrect:

56620 / 56625 / 56630 – Partial or simple vulvectomy

N90.1 – Mild vulvar dysplasia (incorrect severity)

ICD-10-CM Official Guideline:

VIN III is coded as D07.1, not N90.x.

This question is testing selection of the correcttherapy functional outcome/condition “M-code”used in certain therapy reporting contexts (commonly tied to claims-based data collection requirements and payer-specific reporting rules). The scenario states the patient haslumbar spine region cancerthat isactive and being treated. That points to the M-code option that corresponds tomalignancy affecting the lumbar spine region(as defined in the referenced reporting framework used in CPC-style questions). Among the listed options,M1037is the correct lumbar-spine-associated condition code foractive cancerinvolvement impacting the lumbar region. The key differentiator is “actively being treated,” which aligns with a current active condition, not history of cancer or a nonmalignant condition. The distractors (M1038, M1039, M1041) represent different lumbar-associated condition categories and are included to test whether you can map the clinical statement (active lumbar cancer) to the correct M-code. Therefore, the correct selection isM1037.

88299 = Unlisted cytogenetic study

Other unlisted codes are for chemistry, immunology, or pathology